middle.news
How Patrys’ New Injectable Antipsychotic Could Transform $2B Delirium Market
9:22am on Wednesday 26th of November, 2025 AEDT
•
Healthcare
Read Story
How Patrys’ New Injectable Antipsychotic Could Transform $2B Delirium Market
9:22am on Wednesday 26th of November, 2025 AEDT
Key Points
Acquisition of Reliis adds injectable Quetiapine (RLS-2201) targeting delirium
Addresses a US$2 billion+ global market with no approved acute delirium treatments
Near-term clinical milestones include Phase 0 and Phase I trials planned
Deal includes issuing 110 million shares and 70 million performance rights
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
PAB
OPEN ARTICLE